VALKIGO

Serial Number 88861021
606

Registration Progress

Application Filed
Apr 6, 2020
Under Examination
Oct 6, 2020
Approved for Publication
Aug 11, 2020
Published for Opposition
Aug 11, 2020
Registered

Trademark Image

VALKIGO

Basic Information

Serial Number
88861021
Filing Date
April 6, 2020
Published for Opposition
August 11, 2020
Abandonment Date
May 8, 2023
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
May 8, 2023
Classes
005

Rights Holder

Calliditas Therapeutics AB

99
Address
Kungsbron 1, D5
Stockholm SE-11122
SE

Ownership History

Calliditas Therapeutics AB

Original Applicant
99
Stockholm SE

Calliditas Therapeutics AB

Owner at Publication
99
Stockholm SE

Legal Representation

Attorney
Pam Kohli Jacobson

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

33 events
Date Code Type Description Documents
May 8, 2023 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
May 8, 2023 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Oct 6, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 4, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 4, 2022 EXT4 S SOU EXTENSION 4 FILED Loading...
Oct 4, 2022 EX4G S SOU EXTENSION 4 GRANTED Loading...
Apr 5, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Apr 1, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 1, 2022 EXT3 S SOU EXTENSION 3 FILED Loading...
Apr 1, 2022 EX3G S SOU EXTENSION 3 GRANTED Loading...
Sep 16, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Sep 14, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Sep 14, 2021 EXT2 S SOU EXTENSION 2 FILED Loading...
Sep 14, 2021 EX2G S SOU EXTENSION 2 GRANTED Loading...
Mar 9, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Mar 5, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Mar 5, 2021 EXT1 S SOU EXTENSION 1 FILED Loading...
Mar 5, 2021 EX1G S SOU EXTENSION 1 GRANTED Loading...
Oct 6, 2020 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Aug 11, 2020 PUBO A PUBLISHED FOR OPPOSITION Loading...
Aug 11, 2020 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jul 22, 2020 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jul 9, 2020 FIXD O ELECTRONIC RECORD REVIEW COMPLETE Loading...
Jul 3, 2020 ERRR O ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED Loading...
Jun 29, 2020 ALIE A ASSIGNED TO LIE Loading...
Jun 26, 2020 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Jun 26, 2020 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Jun 26, 2020 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Jun 26, 2020 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Jun 26, 2020 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jun 24, 2020 DOCK D ASSIGNED TO EXAMINER Loading...
Apr 16, 2020 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Apr 9, 2020 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Medical and pharmaceutical preparations for the treatment of kidney diseases, liver diseases, immune system diseases and inflammatory diseases; Diagnostic preparations and materials in the nature of companion diagnostics kits comprising tubes, microtiterplates, diluents, vials, kit instructions, pipetting tools and devices, containers, packaging materials and reagents, kits comprising tubes, microtiterplates, diluents, vials, kit instructions, pipetting tools and devices, containers, packaging materials and reagents for diagnosis and prognosis for medical purposes; Pharmaceutical and natural remedy preparations for the treatment of kidney diseases, liver diseases, immune system diseases and inflammatory diseases; Pharmaceutical drugs for the treatment of kidney diseases, liver diseases, immune system diseases and inflammatory diseases; Pharmaceutical preparations for the treatment of kidney diseases, liver diseases, immune system diseases and inflammatory diseases
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005